Group items tagged

Community pharmacy is stuck in a vicious circle. Pharmacies are closing at an alarming rate whilst the government is talking about moving care away from hospitals and into the community to focus on preventative care. While the government talks about this vision for the future, the stark reality is that pharmacies are already struggling to meet the current Pharmacy First thresholds. And now we discover that one of the key components that could create capacity in pharmacy to deliver more clinical services has been put on hold…indefinitely. The recently published Darzi review, which was commissioned after the new government came to power to assess the state of the NHS, praised the value of community pharmacies and preventative services. But it recognised the level of pharmacy closures across the country and warned pharmacy access could be 'at risk'. Community pharmacy is ideally placed to deliver the government's vision of preventative care in the community. But let's all be clear, moving preventative services into community pharmacies has, so far, been nowhere near as successful as it could have been due to the current climate pharmacies find themselves in. The Pharmacy First scheme is a testament to this. Just this week it was announced that consultation thresholds for the Pharmacy First scheme have been reduced from 30 consultations to 20. It's the second time in three months that the thresholds have been reduced and it follows an intervention from Community Pharmacy England who wanted to "save many pharmacies from missing out on a vital payment this month." In June alone, 3,269 participating pharmacies failed to meet the threshold - that's almost a third of all community pharmacies in England.

Pharmacy First has demonstrated the enormous value of community pharmacy in providing accessible front-line care. However, pharmacists continue to face several challenges in delivering the service. "Pharmacy First is a success, but it needs proper support to reach its full potential," said Numark chairman Harry McQuillan. In the first year alone, community pharmacies in England delivered an incredible 2 million consultations, highlighting the vital role pharmacists and their teams play in supporting the NHS. "This significant number shows the high demand for accessible healthcare and the trust patients place in their local pharmacy teams. It's clear that when empowered, community pharmacy delivers," McQuillan told Pharmacy Business. Key challenges in providing the service While Numark members have embraced Pharmacy First, McQuillan pointed out several challenges that persist: "Workforce capacity continues to be a concern, with patient demand sometimes outpacing available resources. "The administrative burden, particularly around IT interoperability, data capture, and reimbursement processes, adds complexity." "Additionally, some geographical areas are still struggling with public awareness, meaning more work is needed to ensure patients understand when and how they can access Pharmacy First."

The Company Chemists Association (CCA) has published a report highlighting the key findings of a roundtable it hosted earlier this month. The CCA convened the virtual roundtable to examine the best practice undertaken by a cross-section of LPCs to promote the delivery of the Pharmacy First service. Key recommendations for how LPCs can help support pharmacy contractors to deliver the Pharmacy First service include: Direct engagement with NHS regions who can supply funding to drive Pharmacy First engagement and promotional activity. Engagement with a variety of staff within GP surgeries, ranging from reception staff to GP partners, to drive referrals, as well as build understanding and awareness of the benefits to General Practice. Harnessing data to inform GP surgeries how they are performing locally Using data to ensure pharmacies close any open referrals promptly. Using multiple channels to promote the service, including the sharing of best practice, myth busting, use of data and creating tools which can be readily used by pharmacies and GPs. Encouraging pharmacy staff to highlight the Pharmacy First service to customers - with specific emphasis on the provision of NHS-funded care, timely access and convenience the service provides. The CCA said the report is intended to support all LPCs and pharmacy contractors as they work together to care for patients requiring urgent NHS care in their community.

As an Alphega pharmacy mentor, Sue Dobson has worked with pharmacists across the country, helping them adapt to the growing responsibilities and challenges they face in their profession. One of the most exciting developments in recent years has been the Pharmacy First initiative, which positions community pharmacists as key players in patient care, especially through GP referrals. However, Sue has seen firsthand that the success of this initiative depends largely on the strength of the relationships we build with GPs and how we integrate these referrals into our day-to-day operations. Some pharmacists have thrived by establishing strong, collaborative relationships, while others have struggled to break down initial barriers of trust. In this conversation, she speaks with Anil Chauhan, a Preston pharmacist who, along with his partner Yasar Hussain, has made GP referrals a seamless part of their practice. Their success story is a great example of how perseverance, trust-building, and a proactive approach can truly make a difference in the Pharmacy First model. Sue Dobson: Anil, you and Yasar have done a great job with the Pharmacy First initiative and GP referrals. Can you start by sharing how you first got involved with GP referrals and what made it successful in your practice?

Janet Morrison, CEO of Community Pharmacy England (CPE) has emphasised that stabilization of the sector is essential before any solutions can be delivered to fix the "struggling" health service. Speaking at the recent SIGMA UK Community Pharmacy Conference 2024, Janet described the current contract as "unaffordable" and warned that pharmacies are becoming "unsustainable." "Without an urgent funding uplift, the sector is facing a 'house of cards' collapse that will seriously impact communities, patients, and the safety of medicine supply. "So, first of all, we have to secure the stabilization. We have to make sure you can keep the lights on and the doors open, and that's critical," she stated. Janet pointed out that if the sector is stabilized and a fair deal is achieved, community pharmacies could effectively deliver solutions for the government that meet their policy goals. However, she noted that negotiations for the Community Pharmacy Contractual Framework (CPCF) for 2024-2025 cannot resume until the budget is published on October 30.

The two Gompels pharmacies, located one mile away from one another in Melksham, Wiltshire, have recently achieved significant milestones, underscoring the success of their innovative and patient-centric approach. With a remarkable increase in consultations and a surge in the use of the Pharmacy First service, the pharmacies have become a cornerstone of the community's healthcare. So what is the secret sauce that helps the Gompels achieve success? At the heart of Gompels' success is the dedicated staff and the strong work culture cultivated over decades. Patrick Gompels believes in empowering his team through a strong work culture. "Our culture and empowering the team is the most important thing. We have put a huge amount of work into it," he states. Monthly barbecues, drinks evenings, daily huddles, and five-minute reviews with managers reinforce this culture and keep the team connected and motivated. " I send a bulletin to all the staff at the start of every week, and different people chip in and give their input. This constantly reinforces the strategy and changes, further empowering the staff," Gompels says.

In a recent report released by the Company Chemists' Association (CCA), data from the NHS Pharmacy First service indicates a substantial uptake and positive impact on patient care just two months after its launch. The CCA's findings shed light on the service's efficacy in meeting patient needs and its potential to alleviate pressure on General Practices (GPs) within the NHS. According to the report, over 90,000 Pharmacy First consultations were conducted solely by CCA members within the initial two-month period. Impressively, 88 per cent of these consultations, totaling 81,627, were deemed eligible for NHS-funded care indicating a significant demand for the service among patients. In the first month, the data revealed that more than 90 per cent of eligible patients received necessary care directly through Pharmacy First, bypassing the need for further referral.

The Pharmacists' Defence Association (PDA) has partnered with the International Pharmaceutical Federation (FIP) and several national pharmacy leadership organisations from four different global regions to launch a humanitarian relief campaign called 'Medicines to Gaza'. Building on the success of the 'Medicines to Ukraine' campaign, which raised over £4.5 million in collaboration with European pharmacy organisations, the PDA is now extending its humanitarian efforts to support those in need in Gaza. Mark Koziol, PDA chair, said: "I am enormously proud that we have been able to persuade FIP and the national pharmacy leadership organisations from across four different regions of the world to join this important initiative and this is just the start. "This gives significant capacity for our profession to work together to bring humanitarian relief to the people of Gaza." The PDA's 'Medicines To' campaign was endorsed by FIP at its annual conference last year, where South Africa became the first country to officially sign up. Since then, 12 countries have pledged their participation. The campaign aims to provide pharmacy support during humanitarian crises worldwide.

Generic pharmaceutical company Brown & Burk has announced that it is "the first and the only company" to launch the new anti-smoking pill 'Varenicline' in the UK. Available through NHS stop smoking services, the daily pill has been shown to be as effective as vapes and more successful than nicotine replacement gum or patches in helping smokers quit. When combined with behavioural support, such as counselling, Varenicline was found to help one in four smokers quit for at least six months. The company told Pharmacy Business that its Varenicline 1mg and 0.5mg tablets are being distributed by Teva UK, branded with Brown & Burk's livery. Health secretary Wes Streeting recently highlighted the potential benefits of the pill, stating that its rollout could "save the NHS millions of pounds, save appointments to help other patients be seen faster, and save lives." A study by University College London suggested that Varenicline use could help over 85,000 people try to quit smoking each year, potentially preventing up to 9,500 smoking-related deaths over the next five years.